FindTrial
Sign In

Azithromycin Oral Product

DRUG3 trials

Sponsors

Johns Hopkins Bloomberg School of Public Health, University of California, San Francisco, Thomas Jefferson University

Conditions

Campylobacter InfectionsDepression, AnxietyDry EyeEnteric PathogensMalnutrition; ProteinNeuropathic Eye PainOcular MicrobiomePreterm Premature Rupture of Membrane

Phase 2

Protein Plus: Improving Infant Growth Through Diet and Enteric Health
CompletedNCT03683667
Johns Hopkins Bloomberg School of Public HealthCampylobacter Infections, Enteric Pathogens, Malnutrition; Protein +1
Start: 2018-09-23End: 2020-03-24Updated: 2022-12-05

Phase 4

Azithromycin for Meibomian Gland Disease
TerminatedNCT03953118
University of California, San FranciscoDepression, Anxiety, Dry Eye, Neuropathic Eye Pain +1
Start: 2019-09-01End: 2021-07-01Updated: 2025-08-06
Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial
CompletedNCT04294069
Thomas Jefferson UniversityPreterm Premature Rupture of Membrane
Start: 2020-09-14End: 2021-04-01Updated: 2023-07-27

Related Papers

Protein supplementation delivered alone or in combination with presumptive azithromycin treatment for enteric pathogens did not improve linear growth in Bangladeshi infants: results of a cluster-randomized controlled trial
American Journal of Clinical Nutrition2025-01-072 citations
An Egg Intervention Improves Ponderal But Not Linear Growth Among Infants 6-12 mo of Age in Rural Bangladesh.
2024-05-152 citations
Prelacteal feeding is not associated with infant size at 3 months in rural Bangladesh: a prospective cohort study
International Breastfeeding Journal2024-02-273 citations